This is the authors' abstract. We don't add key points for this paper.
imaging of GUS activity are hindered by background interference, which reduces their effectiveness in dynamic biological environments. To address this challenge, we developed Ox-GUS, a GUS-specific fluorescent probe with a unique molecular design featuring a disrupted conjugated structure. This design provided Ox-GUS with near-zero background optical properties, a significantly enhanced signal-to-noise ratio, and a highly sensitive detection ability. The probe demonstrated a fluorescence enhancement of up to 400 folds in response to GUS activity, with a detection limit as low as 0.0035 U/mL. We successfully employed Ox-GUS to visualize GUS activity in real-time in mouse models of rheumatoid arthritis, autoimmune hepatitis, and inflammatory bowel disease, and effectively monitored therapeutic responses. This study highlights the potential of Ox-GUS as a robust tool for advancing research on GUS-related inflammatory mechanisms and for early diagnosis and treatment monitoring of inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: